Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 2 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 2 business days late.
The 8 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER◆ | 116,408 | — | — | — | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | FTAX | 82,527 | $5.07 | $418.4K | -53.3% | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER | 10,456 | $4.39 | $45.9K | +7.2% | Open the original filing on SEC.gov |
| Sep 18 | ABUS | Arbutus Biopharma Corp | MEXER | 116,408 | $3.20 | $372.5K | +415.7% | Open the original filing on SEC.gov |
| Feb 2 | ABUS | Arbutus Biopharma Corp | AGRANT◆ | 71,700 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | ABUS | Arbutus Biopharma Corp | AGRANT | 28,000 | — | — | — | Open the original filing on SEC.gov |